This article provides a comprehensive overview of the incidence, pathophysiology, and management of cardiogenic shock following acute myocardial infarction.
High post-MI cardiogenic shock incidence and mortality require clinical vigilance; leaves open optimal therapies for prospective trials.
In Brief Despite advances in treatment, the mortality rate of patients who develop cardiogenic shock after an acute myocardial infarction remains unacceptably high. This article presents an overview of cardiogenic shock-incidence, epidemiology, predisposing factors, pathophysiology, and management, both medical and surgical. Cardiogenic shock can develop in up to 10% of patients who have a myocardial infarction. This article provides an overview of cardiogenic shock: risk factors, pathophysiology, medical management, and the role of the critical care nurse.
No takes yet. Share an insight, caveat, or question.
Linda Josephson (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: